Drug Discovery and Development

Humanigen, Emergent Enter Covid-19 Partnership

Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.

Tim Wright, Editor, Contract Pharma 01.25.21

Samsung Bioepis Opens New Headquarters

The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.

Tim Wright, Editor, Contract Pharma 01.25.21

Formulation Development

Almac Group

...

Kerry Lyle, Mrs 01.22.21

Breaking News | Drug Development | Drug Discovery | Industry News

Lilly Completes $1B Acquisition of Prevail

Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.

Kristin Brooks 01.22.21

Breaking News | Drug Development | Industry News | Information Technology | Regulatory Affairs

Top BioPharma Form Accumulus Synergy

Aims to develop a cloud-based Global Data Sharing Platform to facilitate data and information sharing between industry and health authorities worldwide.

Kristin Brooks 01.22.21

Formulation Development

Coating Place Wurster Fluid Bed Process Scaling

With a 45-year history of involvement in formulation dev and application, this design strategy lends significant ease and predictability to process scale-up.

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

AbbVie Licenses ProBioGen’s GlymaxX Technology

Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).

Kristin Brooks 01.22.21

Analytical Services | Laboratory Testing

Improving Product Profitability

Using PAT/QbD/CM as tools to increase profitability of products.

Online Exclusives Emil Ciurczak, Contributing Editor 01.21.21

CDMO Northway Biotech Expands in U.S.

Opens new biopharmaceutical manufacturing site in greater Boston area.

Tim Wright, Editor, Contract Pharma 01.21.21

Breaking News | Industry News | Information Technology | Validation

Global Biosciences Co. Selects ValGenesis VLMS

Will digitize the validation service activities for efficient and faster access to validated and safer products across 40 countries.

Contract Pharma Staff 01.20.21

Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News

Nexelis Acquires GSK Vax Lab in Marburg

Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.

Contract Pharma Staff 01.20.21

Clinical Trials

The Future of Clinical Trials Series: Part I

What will 2021 have in store for an industry in flux?

Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Director of Decentralized Solutions, Syneos Health 01.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

JS Bio and Etta Biotech Advancing Partnership

Will set up a high titer transient protein expression platform for high quality protein production.

Contract Pharma Staff 01.19.21

Intravacc Completes Project for Provention Bio’s Vax Candidate

Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.

Contract Pharma Staff 01.19.21

Drug Development

Drug Development For Startups

There is no way to eliminate the risk of failure. However, there are ways to reduce these risks. Learn more in this whitepaper from Recipharm.

Breaking News | Collaborations & Alliances | Drug Discovery

Metrion, LifeArc Extend Neuroscience Alliance

Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.

Contract Pharma Staff 01.18.21

Breaking News | Clinical Trials | Industry News

Grifols Begins COVID-19 Plasma Treatment Trial

Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.

Contract Pharma Staff 01.18.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery